News

Board Changes
16 September 2009

TyraTech, Inc. (AIM: TYR), a leading independent novel eco-technology company for human, animal and environmental health, is pleased to announce that Patrick Regan will join the Board as a Non-Executive Director and that David Paul Szostak will step down from the Board as a Non-Executive Director. Mr Szostak joined the Board in April 2008 to represent XL TechGroup and will now step down from the Board. Both changes take place with immediate effect.

Mr Regan thirty seven joins the Board as a representative of the Laurus-Valens Group, the parent Group of PetroTech Holdings Corporation, which has a 45.69% shareholding in TyraTech. He brings to the Board over sixteen years of financial analysis, corporate management, investment banking and venture capital experience gained in the US. Mr Regan has been a senior managing director for Laurus Capital Management LLC since 2001 and has also served the same role at Valens Capital Management LLC since its establishment in 2007.

In addition to his fund management experience at Laurus-Valens, he has spent four years as a financial analyst at Geller & Company, a financial services accounting firm, primarily providing CFO functions to private companies and financial planning for high net worth individuals. At Geller, he was involved in private placement financing, management consulting and general corporate finance functions. Between 1999 and 2001, Patrick Regan was an associate at Tower Hill Capital Group, an investment banking boutique and venture capital firm

Mr Regan has a Bachelor of Science in Business and Economics from Lehigh University and an MBA from Fordham University.

Mr. Regan has no other previous or current Directorships.

There are no further details required to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM Rules.

Commenting on the board changes Geoffrey Vernon, Chairman of TyraTech, said:

“I am delighted to welcome Patrick Regan to the Board as he brings a wealth of experience of matters across a range of different areas important to TyraTech. His understanding of the financial dynamics of small cap companies and his investment banking and venture capital experience will be beneficial to the Group.”

“I would like to express my sincere gratitude to David for his experience and expertise throughout his time at TyraTech and wish him well for the future. His contribution has been highly valuable.” 

 

For further information please contact:

TyraTech Inc. Alan Reade, Executive Chairman www.tyratech.com	1 (321) 409 - 7720
Nomura Code Securities Charles Walker/Clare Terlouw www.nomuracode.com	+44 (0)20 7776 1200
Buchanan Communications Mary-Jane Elliott/Lisa Baderoon/ Catherine Breen/Stasa Filiplic www.buchanan.uk.com	+44 (0) 20 7466 5000

 

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has products on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally.  TyraTech’s Nature’s Technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech’s plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for consumer and professional pest control.  TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com

 

<< Back to News releases